These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31705174)

  • 1. The P2X
    Hagens MHJ; Golla SSV; Janssen B; Vugts DJ; Beaino W; Windhorst AD; O'Brien-Brown J; Kassiou M; Schuit RC; Schwarte LA; de Vries HE; Killestein J; Barkhof F; van Berckel BNM; Lammertsma AA
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):379-389. PubMed ID: 31705174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of P2X
    Beaino W; Janssen B; Kooijman E; Vos R; Schuit RC; O'Brien-Brown J; Kassiou M; van Het Hof B; Vugts DJ; de Vries HE; Windhorst AD
    J Neuroinflammation; 2020 Oct; 17(1):300. PubMed ID: 33054803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of the purinergic P2X
    Brumberg J; Aarnio R; Forsberg A; Marjamäki P; Kerstens V; Moein MM; Nag S; Wahlroos S; Kassiou M; Windhorst AD; Halldin C; Haaparanta-Solin M; Fazio P; Oikonen V; Rinne JO; Varrone A
    J Cereb Blood Flow Metab; 2023 Feb; 43(2):258-268. PubMed ID: 36163685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [
    Hagens MHJ; Golla SV; Wijburg MT; Yaqub M; Heijtel D; Steenwijk MD; Schober P; Brevé JJP; Schuit RC; Reekie TA; Kassiou M; van Dam AM; Windhorst AD; Killestein J; Barkhof F; van Berckel BNM; Lammertsma AA
    J Neuroinflammation; 2018 Nov; 15(1):314. PubMed ID: 30424780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
    Takano A; Piehl F; Hillert J; Varrone A; Nag S; Gulyás B; Stenkrona P; Villemagne VL; Rowe CC; Macdonell R; Tawil NA; Kucinski T; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Halldin C
    EJNMMI Res; 2013 Apr; 3(1):30. PubMed ID: 23618062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [
    Alzghool OM; Aarnio R; Helin JS; Wahlroos S; Keller T; Matilainen M; Solis J; Danon JJ; Kassiou M; Snellman A; Solin O; Rinne JO; Haaparanta-Solin M
    EJNMMI Res; 2024 Mar; 14(1):25. PubMed ID: 38446249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the allosteric P2X
    Janssen B; Vugts DJ; Wilkinson SM; Ory D; Chalon S; Hoozemans JJM; Schuit RC; Beaino W; Kooijman EJM; van den Hoek J; Chishty M; Doméné A; Van der Perren A; Villa A; Maggi A; Molenaar GT; Funke U; Shevchenko RV; Baekelandt V; Bormans G; Lammertsma AA; Kassiou M; Windhorst AD
    Sci Rep; 2018 Apr; 8(1):6580. PubMed ID: 29700413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSPO PET with [
    Unterrainer M; Mahler C; Vomacka L; Lindner S; Havla J; Brendel M; Böning G; Ertl-Wagner B; Kümpfel T; Milenkovic VM; Rupprecht R; Kerschensteiner M; Bartenstein P; Albert NL
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1423-1431. PubMed ID: 29523925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation.
    Ricigliano VAG; Morena E; Colombi A; Tonietto M; Hamzaoui M; Poirion E; Bottlaender M; Gervais P; Louapre C; Bodini B; Stankoff B
    Radiology; 2021 Oct; 301(1):166-177. PubMed ID: 34254858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
    Ahmad R; Postnov A; Bormans G; Versijpt J; Vandenbulcke M; Van Laere K
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2219-2227. PubMed ID: 27488857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 15. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach in radiometabolite analysis of positron emission tomography (PET) radioligands; lead-shielded microextraction by packed sorbent as a tool for in vivo radiometabolite analysis of [
    Moein MM; Tóth M; Tari L; Varrone A; Abdel-Rehim M; Halldin C
    Talanta; 2020 Feb; 208():120449. PubMed ID: 31816716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study.
    Pitombeira MS; Koole M; Campanholo KR; Souza AM; Duran FLS; Solla DJF; Mendes MF; Pereira SLA; Rimkus CM; Busatto GF; Callegaro D; Buchpiguel CA; de Paula Faria D
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4551-4566. PubMed ID: 35838758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Van Weehaeghe D; Koole M; Schmidt ME; Deman S; Jacobs AH; Souche E; Serdons K; Sunaert S; Bormans G; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2051-2064. PubMed ID: 31243495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.
    Zhang L; Hu K; Shao T; Hou L; Zhang S; Ye W; Josephson L; Meyer JH; Zhang MR; Vasdev N; Wang J; Xu H; Wang L; Liang SH
    Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis.
    Beaino W; Janssen B; Kooij G; van der Pol SMA; van Het Hof B; van Horssen J; Windhorst AD; de Vries HE
    J Neuroinflammation; 2017 Dec; 14(1):259. PubMed ID: 29273052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.